ALJ’s Illumina/Grail decision ignored existing competition, FTC says

The Federal Trade Commission’s administrative law judge misunderstood the market when he ruled that Illumina has no incentive to foreclose competition through its acquisition of Grail because the latter’s early cancer-detection tests are not yet on sale, agency staff has argued.

Unlock unlimited access to all Global Competition Review content